Impact of cognitive therapy on internalised stigma in people with at-risk mental states

British Journal of Psychiatry

Volumn 203, Issue 2, 2013, Pages 140-145

  Morrison, Anthony P ^a   Birchwood, Max ^b   Pyle, Melissa ^a   Flach, Clare ^c   Stewart, Suzanne L K ^a   Byrne, Rory ^a   Patterson, Paul ^b   Jones, Peter B ^d   Fowler, David ^e   Gumley, Andrew I ^e   French, Paul ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^f GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COGNITIVE THERAPY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MONITORING; OUTCOME ASSESSMENT; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; STIGMA; TREATMENT DURATION;

ADOLESCENT; ADULT; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOTIC DISORDERS; RISK FACTORS; SELF CONCEPT; SINGLE-BLIND METHOD; SOCIAL STIGMA; TREATMENT OUTCOME;

EID: 84881124468     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.112.123703     Document Type: Article

References (38)

1. Yung AR, McGorry PD, McFarlane C, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996; 22: 283-303.
2. Yang LH, Wonpat-Borja AJ, Opler MG, Corcoran CM. Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question. Schizophr Res 2010; 120: 42-8.
3. Corcoran CM, First MB, Cornblatt BA. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk/benefit analysis. Schizophr Res 2010; 120: 16-22.
4. Morrison AP, Byrne RE, Bentall RP. DSM-5 and the 'Psychosis Risk Syndrome': whose best interests would it serve? Psychosis 2010; 2: 96-9.
5. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 2011; 125: 54-61.
6. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163: 790-9.
7. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 921-8.
8. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Randomised controlled trial. Br J Psychiatry 2004; 185: 291-7.
9. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67: 146-54.
10. Bechdolf A, Wagner M, Ruhrmann S, Harrigan S, Putzfeld V, Pukrop R, et al. Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry 2012; 200: 22-9.
11. Yung AR, Phillips LJ, Nelson B, Francey SM, PanYuen H, Simmons MB, et al. Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry 2011; 72: 430-40.
12. Morrison AP, French P, Stewart S, Birchwood M, Fowler B, Gumley AI. Early Detection and Intervention Evaluation for people at risk of psychosis (EDIE-2): a multisite randomised controlled trial of cognitive therapy for at risk mental states. BMJ 2012; 344: e2233.
13. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ 2013; 346: f185.
14. Warner R. The prevention of schizophrenia: what interventions are safe and effective? Schizophr Bull 2001; 27: 551-62.
15. Corcoran C, Malaspina D, Hercher L. Prodromal interventions for schizophrenia vulnerability: the risks of being ''at risk''. Schizophr Res 2005; 73: 173-84.
16. French P, Morrison AP. Early Detection and Cognitive Therapy for People at High Risk of Developing Psychosis: A Treatment Approach. Wiley, 2004.
17. Bentall RP, Morrison AP. More harm than good: the case against using antipsychotic drugs to prevent severe mental illness. J Ment Health 2002; 11: 351-65.
18. Link BG, Yang LH, Phelan JC, Collins PY. Measuring mental illness stigma. Schizophr Bull 2004; 30: 511-41.
19. Corrigan PW, Watson AC. The paradox of self-stigma and mental illness. Clin Psychol 2002; 9: 35-53.
20. Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res 2003; 121: 31-49.
21. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Mapping the onset of psychosis - the comprehensive assessment of at risk mental states (CAARMS). Aust N Z J Psychiatry 2005; 39: 964-71.
22. Birchwood M, Mason R, MacMillan F, Healy J. Depression, demoralization and control over psychotic illness: a comparison of depressed and nondepressed patients with a chronic psychosis. Psychol Med 1993; 23: 387-95.
23. Birchwood M, Jackson C, Brunet K, Holden J, Barton K. Personal Beliefs about Illness Questionnaire-Revised (PBIQ-R): reliability and validation in a first episode sample. Br J Clin Psychology 2012; 51: 448-58.
24. Morrison AP. The interpretation of intrusions in psychosis: an integrative cognitive approach to hallucinations and delusions. Behav Cogn Psychother 2001; 29: 257-76.
25. Little RJA, Rubin DB. Statistical Analysis with Missing Data. John Wiley and Sons, 2002.
26. Maracy M, Dunn G. Estimating dose-response effects in psychological treatment trials: the role of instrumental variables. Stat Methods Med Res 2011; 20: 191-215.
27. Morrison AP, Stewart S, French P, Bentall RP, Birchwood M, Byrne R, et al. Early Detection and Intervention Evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics. Early Interv Psychiatry 2011; 5: 24-32.
28. Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull 2009; 35: 841-3.
29. Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M. Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet 2009; 373: 408-15.
30. Goffman E. Stigma: Notes on the Management of Spoiled Identity. Penguin Books, 1963.
31. Brohan E, Elgie R, Sartorius N, Thornicroft G. Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: the GAMIAN-Europe study. Schizophr Res 2010; 122: 232-8.
32. Thornicroft G. Most people with mental illness are not treated. Lancet 2007; 370: 807-8.
33. Thornicroft G, Rose D, Kassam A. Discrimination in health care against people with mental illness. Int Rev Psychiatry 2007; 19: 113-22.
34. Corrigan PW, Watson AC, Barr L. The self-stigma of mental illness: implications for self-esteem and self-efficacy. J Soc Clin Psychol 2006; 25: 875-84.
35. Birchwood M, Trower P, Brunet K, Gilbert P, Iqbal Z, Jackson C. Social anxiety and the shame of psychosis: a study in first episode psychosis. Behav Res Ther 2007; 45: 1025-37.
36. Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med 2010; 71: 2150-61.
37. Byrne R, Morrison AP. Young people at risk of psychosis: their subjective experiences of monitoring and cognitive behaviour therapy in the EDIE 2 trial. Psychol Psychother, in press.
38. International Early Psychosis Association Writing Group. International clinical practice guidelines for early psychosis. Br J Psychiatry 2005; 187 (suppl 48): s120-4.